Skip to content

A Randomized Controlled Trial to Assess the Effectiveness and Safety of Acupuncture for Overactive Bladder: A Study in Hong Kong Patient Population

A Randomized Controlled Trial to Assess the Effectiveness and Safety of Acupuncture for Overactive Bladder: A Study in Hong Kong Patient Population

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16010048
Enrollment
Unknown
Registered
2016-11-29
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder

Interventions

Two groups:Acupuncture 30-minute for 8 weeks versus Sham acupuncture without penetrating into skin for 8 weeks

Sponsors

The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: Both male and female elderly at the age between 60 to 90 years old; Diagnosed as OAB wet-type (3 or more episodes of incontinence in the past 4 weeks that are no stress-incontinence) according to the diagnosis criteria of the ICS;Physically and mentally able to complete the 7-day voiding diary, Urinary Distress Inventory (UDI-6) and Incontinence Impact questionnaire (IIQ7) Able to give written inform consent (by patients themselves or by caretaker).

Exclusion criteria

Exclusion criteria: OAB symptom caused by stroke or spinal injury; Life threatening infection; Unconsciousness or severe cognition deficits; Dementia caused by Alzheimers disease or other neurodegenerative diseases; Undergone incontinence surgery previously; On short-term active diuretic treatment or taking diuretic medication; Had previously received acupuncture treatment for any medical conditions; Patients who are on drug treatment for OAB; Patients who diagnosed as stress urinary incontinence; Pregnancy; Suffering the following diseases: untreated urinary tract infection, urogenital tumors, prostate tumor, benign prostatic hyperplasia, chronic urinary retention.

Design outcomes

Primary

MeasureTime frame
7-day voiding diary;

Secondary

MeasureTime frame
Urine NGF level;

Countries

China

Contacts

Public ContactLIN Zhixiu

School of Chinese Medicine, CUHK

linzx@cuhk.edu.hk+852 39436347

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 6, 2026